Arovella snaffles R&D rebate worth $3M for cancer cell therapy research
Arovella Therapeutics Ltd (ASX:ALA) has received a $3 million research and development…
Arovella Therapeutics Limited (ASX:ALA)
About Arovella Therapeutics Limited
Key Information
ALA In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 29/11/2024 | Change of Director's Interest Notice x5 | 876.7KB | 383 |
| 26/11/2024 | Notification regarding unquoted securities - ALA | 16.9KB | 268 |
| 15/11/2024 | Notice Under Section 708A | 213.96KB | 271 |
| 15/11/2024 | Application for quotation of securities - ALA | 15.56KB | 218 |
| 15/11/2024 | Results of Annual General Meeting | 219.36KB | 285 |
| 15/11/2024 | AGM Chairman's Address and CEO & MD Presentation | 3.17MB | 448 |
| 13/11/2024 | Notice Under Section 708A | 213.17KB | 289 |
| 13/11/2024 | Application for quotation of securities - ALA | 15.57KB | 556 |